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Abstract: Background: Hypertension, Diabetes Mellitus and Cardiovascular Diseases are the most common 
and prevalent disease worldwide. Atherosclerosis particularly severe atherosclerosis and its complication are 
the underlying process responsible for almost all cases of ischemic heart disease. Atherosclerosis produces 
significant cardiac morbidity such as angina ,myocardial infarction, Ischemic cardiomyopathy and sudden 
death. Other risk factors includes age, sex and heredity as modified risk factors. Genetically determined risk 
factor such as hyperlipidemia is first one in this regard. 
Objective: To Determine the correlation of apolipoprotein with lipid profile 
Methods: The study was carried out in Fifty four patients of age between 25 to 65 years having 
hypercholesterolemia and 54 healthy male having normal cholesterol levels. Blood samples were drawn after 
informed consent. Glucose tolerance test was done and lipid profile after over night fast were detected.2ml of 
whole bloodwas kept for genetic analysis. Isolated DNA was then polymerized to determine the genotypes at 
EcoR1 polymorphic site of apoB by Polymerase chain reaction.Data analysis was done by SPSS version 18. 
Results:  Allelic frequencies of homozygous and heterozygous individuals were obatainedby gene counting.By 
comparing them its was found that there was no significant difference between the two groups. 
Conclusion: There  was no correlation of allelic frequencies of polymorphism between hperlipidemic and 
normolipidemic subjects. 
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I. Introduction 
Cardiovascular Diseases are one of the leading cause of death world wide .While the term technically 
refers to any disease that affects the cardiovascular system. An estimated 16.7 million or 29.2% of total global 
deaths-results from the various forms of cardiovascular disease (CVS), many of which are preventable by action 
on the major primary risk factors: unhealthy diet, lack of physical activity, and smoking etc. Other risk factors   
as evident from by the observation of Cornfield and Mitchell (1969) including age, sex and heredity(1). Osler 
was one of the first who emphasized the importance of genetic factor in pathogenesis of coronary artery disease. 
The   aggregation is largely due to clustering of genetically determined risk factors such as hyperlipidemia, 
Diabetes Mellitus and hypertension (2). But it has also been that many of coronary heart disease have none of 
these factors. Hyperlilpidemia is the  most important risk  for atherosclerosis, as it affects mainly larger arteries 
while hypertension affects mainly smaller vessels. These lipid include Cholesterol, cholesterol ester , 
phospholipids and triglycerides. They are transported in the blood as part of large molecules called 
lipoproteins..There are five major families of blood (plasma) lipoprotein named ,Chylomicrons, vary low 
density-lipoproteins(VLDL), Intermediate-density lipoprotein(IDL), Low-density lipoprotein (LDL) and High 
density lipoprotein(HDL). Some research associate suggested that protein part of lipoprotein play crucial role in 
discriminating the atherosclerotic patients from the control, rather than lipid component (3). This protein part is 
called apoprotein or apolipoprotein. Studies to determine the relationship of apoprotein with atherosclerosis 
should be carried out.Apo-lipoprotein regulate lipoprotein metabolism , binds and transports lipids, react with 
tissue receptors and are genetic disorder.Apolipoprotein discovered by Berg et al in 1963 (4).Multiple studies 
revealed that the association of the abnormal levels of different lipoprotein and the vascular disease is not 
consistent.But it is found that abnormalities of LDL cholesterol is associated mainly atherosclerosis and 
peripheral vascular disease. Recent lipid profile studies have shown that shown that serum levels of 
apolipoprotein B (ApoB) are better determining markers of risk of vascular diseases. ApoB  exist in human 
plasma , as two isoforms, apo B48 and B-100 is the major physiological ligand for LDL receptor.It is the largest 
manomeric protein sequenced so far, containg 4536 amino acid residues(5,6,7).Its gene has been mapped on the 
short arm of chromosomes 2, with an approximate length of 43 kilo bases and 29 exons (8).Mutations occurring 
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in the apo B gene can alter blood cholesterol level. Two mutations in the apo B gene have been associated with 
elevated blood cholesterol. An association between elevated Triglycerides and the absence of the EcoR1 cutting 
site has been reported in coronary heart disease patients and in healthy males (9,10,11). In our population, 
individual homozygous for the EcoR1 restriction site had slow LDL catabolic rates associated with high LDL 
and total cholesterol values. In another study DNA polymorphism (EcoR1) of APO-B and its relationship with 
vascular dementia or Alzheimer disease and concluded that total cholesterol and LDL cholesterol levels are 
lower in Alzheimer disease patients than in vascular dementia patients and in elderly control (12,13,14) In 
dementia patients with ApoB, EcoR1 R+R-  genotype had increased total cholesterol and LDL cholesterol levels 
than R+R+ homozygotes. In 2000 Tania studied the role of polymorphism and mutations of Apo B particle as 
etiologic factors of hypercholesterolemia in a population of moderately hypercholesterolemia individuals.  
Several restriction fragment length polymorphisms (RFLP) in the Apo B gene have been defined (15).Advances 
in molecular cardiology have revealed a number of single nucleotide polymorphism associated with 
atherosclerosis and contribute to be a risk factor for cardiovascular diseases. 
Aim and Objective: 
To study the EcoR1 Polymorphism of Apo B gene 
 
II. Material and Methods. 
Sample Collection.  
After an informed consent, blood samples were collected by venipuncture under aspetic condition in 
EDTA vials from subjects  fulfilling the inclusion and exclusion criteria.All sample were collected in morning 
after an overnight fasting and 2 ml of whole blood were kept for kept for genetic analysis and rest was kept  for 
lipid profle and blood glucose level. 
 
Inclusion criteria/Exclusion Critaria: 
Patients of age between 25 to 65 , with the total cholesterol more than 250mg/dl were included as a 
case. And patient having Diabetes, hypertension or hyperglycemia or taking drugs were excluded. Healthy 
subjects between age 25 to 65 with total cholesterol less than 200mg/dl and triglyceride less than200mg/dl were 
taken as control. Glucose tolerance test according to standard W.H.O guidelines was done on every patient to 
exclude patients with Diabetes. 
TG levels by choloroform sialiac acid method and serum glucose by Glucose oxidase-peroxidase 
enzymatic method. High density lipoprotein level were calculated by precipitation method.This method involves 
combination of ultracentrifugation to remove chylomicron and VLDL and precipitation with heparin MncL2 to 
remove IDL,LDL ,Lpa leaving HDL. Low density lipoprotein and vary low density lipoprotein by Friedwald 
formulae. 
 
DNA Isolation.  
Blood sample of 2 ml was collected in EDTA vials for genetic analysis-genomic DNA was isolated 
using  whole blood DNA isolation kit by standard method.Genomic DNA was analysed on 1%  agarose gel and 
observed under UV transilluminator. Isolated DNA was then  polymerized to determine the genotypes at EcoR1 
polymorphic site of apoBby polymerase chain reaction by using site specific primers and using PCR master mix 
kits. For EcoR1 Site  primers are 
 Farward primer (F) 5’- CTG AGA GAA GTG TCT TCG AAG -3’  
Reverse primer ( R ) 5’- CTC GAA AGG AAG TGT AAT CAC -3’ 
Agarose gel was prepared to analyse PCR  results and sample were loaded on to 1.5% agarose gel and seen 
under UV transilluminator.PCR products for 400bp was to be amplified detected by comparing with Ladder. 
 
Restriction Digestion 
Restriction digestions of amplicons was done us in restriction enzyme EcoR1 follwed by 
electrophoresis  of  the reaction mix of restriction endonuclease digestion on 1.2% agarose gel in TAE  buffer at 
a contant voltage of 100V.ss DNA bands thus separated are Visualised on UV transilluminators. For the EcoR1 
site, a 400bp fragement was digested with EcoR1 into two fragments of 223 bp and 257 bp in the presence of 
cutting site (E+allele). 
 
III. Discussion 
Table 4 Shows that there was no significance differences in the genotype and allele frequencies of E 
coR1 polymorphism between hyperlipidemic and normolipidemic subjects. The findings are similar to the 
observations made in a Caucasians population in USA, Although the apo-B gene polymorphism did not have 
any significance on the lipid levels, there was an association of IX and R1allele with CHD. Association of the X 
+ allele and TC, TG, and LDLc levels in Caucasians population has been demonstrated repeatedly. Similar 
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finding are also demonstrated in Ascian Indians settled in Singapore, where the X+ allele was significantly 
associated with high levels of serum TC,TG and low HDL-c. Renges  at el showed that in Asian Indian in 
UK,X+ allele was associated with a low HDL-c level(16). 
There may be several reasons for the differences observed in various studies. A simple explanation 
could be that the population studied by Saha at el and Renges et al (16,17). were genetically distinctive , 
consisting of Indian  from southern states of Indian and from the state of Punjab ,respectively. Moreover, gene 
environment interplay may also account for the differential data  since there may be substantial differences in 
the diet and life style of Indians settled in other countries when compared to the north Indian population studied 
by us. Further the sample size of current study being small, larger study would answer the questions in a more 
definitive manner. The RFLP detected by Xba1 is due to a linkage disequilibrium with ins/del polymorphism, 
which causes an amino acid change in a single peptide of the apo-B gene. Absence of an association between 
EcoR1 polymorphism of apo B.     
The RFLP detected with EcoR1   is due to single base pair change in coding region of the gene, which 
is known to cause an amino acid change in the apo-B by itself. This phenomenon may explain the general 
concurrence of our finding with other workers regarding correlation between EcoR1 polymorphism and serum 
lipid levels with E-allele has been rarely described, except in a study of Canadian population. 
Results: 
Apolipoprotein –B(ApoB) is involved in assembly and secretion of chylomicron from small intestine and vary 
low density lipoprotein cholesterol VLDL-c from liver. The apo-B  is located on the short arm of chromosome 
2. Out of total 104 subject under the age of 25 to 65 ,54 had hyperlipidemia were named as group I and 54 were 
normolipidemic were named as group II. Table 1 shows Oligonucleotide primer used for the amplification. 
 
Primers                Sequence 
EcoR1Farward (F) 5’- CTG AGA GAA GTG TCT TCG AAG -3’ 
EcoR1Reverse ( R ) 5’- CTC GAA AGG AAG TGT AAT CAC -3’ 
 
Table:1 Oligonucleotide primer used for the amplification 
Apo B gene was amplified using the primer specific for the segment of gene Apo B gene which include a single 
EcoR1 site as shown in Table:2 
 
Primers Expected Band Size  Observed Band size 
EcoR1 400pb Approx 400bp 
Table 2:  Oligonucleotide primer used for the amplification 
 
Restriction Digestion: 
The allele status (homozygous and heterozygous) of the ampilcons obatained from different samples, was 
analyzed by restriction with EcoR1.X-allele was responsible for absence of EcoR1 site and X+ allele was 
responsible for the presence of EcoR1 site. But for both cases the flanking region of gene segments were 
same,hence both types of allele was amplified. If X-X- allele was present, 400 bp was obtained. If X+X-allele 
was present, three bands 400bp, 253bp,227bp were obtained.(X+X+ homozygous condition for the presence of 
EcoR1,X-X- homozygous condition for the absence of EcoR1,and X+X- is heterozygous condition(Table.03). 
 
Allelic status of Group I 
Sampleno1,3,4,5,7,8,11,12,13,16,17,19,21,22,23,35,26,29,30,31,34,35,39,40,41,43,44,47,48,49,52,53.of group I 
had allelic status X+X+ ,sample no. 6,10,18,24,28,36,42,46,54 of group I had allelic status X-X-,sample 
no.2,9,14,15,32,33,38,45,50,51 of group I had allelic status X+X-(fig.9,10,11) 
 
Allelic status of Group I 
Sample no 1,2,5,6,8,10,11,16,17,18,19,22,23,25,27,28,29,30,31,34,35,36 
39,40,41,47,48,49,53 of group II had allelic status X+X+, Sample no.42 ,46 
50,51 of group II had allelic status X-X- ,Sample no.3,4,7,9,12,13,14,20,21, 
24,26,32,33,37,38,43,44,45,52,54 of group II had allelic status X+X-. 
 
Correlation of ApoB gene and hyperlipidemia 
The correlation of X+(X+X+ and X+X-) and X-(X-X-) and lipid value was determined by the r value 
(correlation coefficient). 
 
                  ∑ xy-  ∑ x
. 
  ∑y/n 
R = 
                    [  ∑ x- ( ∑ x)/n][  ∑y –(∑y/n ] 
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Correlation in case if group I 
In order to find out correlation between ApoB gene polymorphism and higher levels of either serum Tc or Tg , 
different allele condition were assumed as- 
For X-X- (Homozygous condition, restriction site absent)-0 
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Table 3: Restriction analysis of  Amplicons. 
Allele Condition Expected Bands Expected Size in base 
Pair 
 Observed Bands Observed Size in Base 
Pair  
X-X- 1 400 1 400 
X+X+ 2 253,227 2 253,227 
X+X- 3 400,253,227 3 400,253,227 
 
(Tabble.4) Allele frequencies of homozygous and heterozygeous  individuals were obtained by gene counting 
 X+X+ X+X- X-X- X+ X- 
Group I 27/54 21/54 4/54 49/54 27/54 
Frequency 0.52 0.38 0.04 0.90 0.50 
GroupII 24/54 23/54 6/54 48/54 22/54 
Frequency 0.44 0.42 0.11 0.88 0.40 
 
*By comparing allelic frequencies it is found that the frequency of X+ and X- in group I were 0.90and 0.50 
respectively and in group II were 0.88 and 0.40 respectively. 
*By comparing them it was found that there was no significant difference between the two groups. 
 
                  ∑ xy-  ∑ x
. 
  ∑y/n 
R = 
                    [  ∑ x- ( ∑ x)/n][  ∑y –(∑y/n ] 
r  value calculated by the above formula gave value 0 ,this signifies no correlation between allelic condition and 
lipid value of group I (Hyperlipidemic subjects). 
Similarly correlation between  allelic conditions and lipid value of group II (normolipidemic subjects) ,the r 
value calculated also gave value 0. 
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IV. Conclusion 
No correlation was observed betweeb allelic condition and hyperlipidemia and allelic condition and 
normolipidemia, therefore it eas concluded that there was no correlation of allelic frequencies of polymorphism 
between hyperlipidemic and normolipidemic subjects.  
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